Vivia Biotech can
identify the best drugs
for MM patient
enhancing your MM
processes thanks to
our improved and
novel assays and to
the access to
from real patients
Vivia Biotech has access to primary samples from patients diagnosed with a variety of hematological malignancies including MM and can provide extremely valuable data making the difference in your drug development pipeline.
MM Patient Samples Availability & Experience in MM
Vivia MM assays in a nutshell…
We have specific assays to cover the different mechanisms of action of many drugs and compounds and to capture
the effects of apoptosis, proliferation, T-Cell Engagers, T or NK immune cell modulation, antibody-dependent cellular
cytotoxicity or complement dependent cytotoxicity between others and its selectivity, directly on fresh MM patient
Our key innovations supply sound pharmacology using real MM patient samples.